Making the decision to participate in a clinical trial is a very personal one. Some individuals do it because they have run out of options and want to try a new experimental treatment in the hope it might help their condition, while others do it because they want to do their part helping the clinical community move forward and potentially help cure many people down the line.
Clinical trials vary in time; in total a single clinical trial may take up to 15 years to complete, and some longitudinal studies ask the participant to stay in touch for follow up questions for a few years after their participation in the study is finished. Depending on the goal and the design of a clinical trial, volunteers may be asked to stay on site for a set amount of nights; this happens because the researchers might want to monitor the participant’s at different hours of the day or night.
In Michigan, the University of Michigan division of research has one of the largest clinical trial and research centers in the state, where interested volunteers can enroll in studies for healthy or non-healthy individuals. The Barbara Ann Karmanos cancer institute in Detroit, Michigan also offers clinical trials for many types of cancers for both healthy and non-healthy individuals.
Volunteers who decide to participate in a clinical trial may be compensated for their time and travel expenses during their participation in the study. The compensation will vary depending on the type of study and level of participation required from the volunteer.
Participating in a clinical trial is always completely voluntary. This means that nobody, regardless of their condition can be forced to participate nor can they be forced to continue participating in a trial if they wish to withdraw from the study. Non-healthy individuals who decide to enroll in a clinical trial after a suggestion from their doctor or to try an experimental treatment for their condition will never be denied care if they decide to drop out of the study.
A Study to Evaluate the Safety of MEDI8897 for the Prevention of Medically Attended Respiratory Syncytial Virus(RSV) Lower Respiratory Track Infection (LRTI) in High-risk Children
on May 22, 2019 at 4:00 pm
Condition: Respiratory Syncytial Virus InfectionsInterventions: Drug: MEDI8897; Drug: PalivizumabSponsor: MedImmune LLCNot yet recruiting […]
TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)
on May 22, 2019 at 4:00 pm
Conditions: Acute Leukemia; CML; Myelodysplasia; LymphomaInterventions: Procedure: Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Methotrexate; Drug: Tacrolimus; Drug: Methotrexate; Procedure: Mobilized Peripheral Blood Stem Cell graft with Tacrolimus/Mycophenolate Mofetil/Post-Transplant Cyclophosphamide; […]
Simultaneous Cochlear Implantation During Translabyrinthine Resection of Vestibular Schwannoma
on May 21, 2019 at 4:00 pm
Conditions: Vestibular Schwannoma; Cochlear ImplantationIntervention: Device: Cochlear implantSponsor: Ascension South East MichiganRecruiting […]
Mechanical Ventilation Discontinuation Practices
on May 20, 2019 at 4:00 pm
Conditions: Invasive Mechanical Ventilation; Critical Illness; Spontaneous Breathing Trial; Weaning Invasive Mechanical Ventilation; Tracheostomy; Direct ExtubationIntervention: Sponsor: St. Michael's Hospital, TorontoCompleted […]
Study of CPI-200 in Patients With Advanced Tumors
on May 17, 2019 at 4:00 pm
Condition: Advanced Solid TumorIntervention: Drug: CPI-200Sponsor: Coordination Pharmaceuticals, Inc.Not yet recruiting […]
Study of the Safety and Efficacy of Elagolix in Women With Polycystic Ovary Syndrome
on May 15, 2019 at 4:00 pm
Condition: Polycystic Ovary SyndromeInterventions: Drug: Elagolix; Drug: PlaceboSponsor: AbbVieNot yet recruiting […]
Study to Evaluate Arthroplasty Specimens for Osteoarthritis of the Knee and Hip
on May 14, 2019 at 4:00 pm
Conditions: Osteoarthritis, Knee; Osteoarthritis, HipInterventions: Drug: Fasinumab; Drug: Naproxen; Drug: Diclofenac; Drug: Celecoxib; Drug: PlaceboSponsors: Regeneron Pharmaceuticals; Teva Pharmaceutical Industries, Ltd.Enrolling by invitation […]
Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial
on May 13, 2019 at 4:00 pm
Condition: ST Elevation (STEMI) Myocardial Infarction of Anterior WallIntervention: Device: Impella CP® placement prior to reperfusion with Primary PCISponsor: Abiomed Inc.Not yet recruiting […]